1,2-Dihydro-3,1-benzoxazin-4-one and 4H-1,2-dihydro-pyrido-[2,3-d]- [1,3]-oxazin-4-one derivatives as potential prodrugs. Part I: Synthesis. 1991

G Schwenker, and J B Chen
Pharmazeutisch-chemisches Institut, Universität Heidelberg.

UI MeSH Term Description Entries
D009544 Niflumic Acid An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. Donalgin,Flunir,Niflactol,Niflugel,Nifluril,Acid, Niflumic
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.

Related Publications

G Schwenker, and J B Chen
May 1963, Journal of medicinal chemistry,
G Schwenker, and J B Chen
December 2008, Acta crystallographica. Section E, Structure reports online,
G Schwenker, and J B Chen
September 1968, Journal of medicinal chemistry,
G Schwenker, and J B Chen
January 1982, Die Pharmazie,
G Schwenker, and J B Chen
July 2004, Molecules (Basel, Switzerland),
G Schwenker, and J B Chen
November 1971, Journal of pharmaceutical sciences,
G Schwenker, and J B Chen
May 1993, The Journal of pharmacology and experimental therapeutics,
G Schwenker, and J B Chen
July 1981, Journal of medicinal chemistry,
G Schwenker, and J B Chen
January 2004, Rapid communications in mass spectrometry : RCM,
Copied contents to your clipboard!